Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series The BMJ
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series The BMJ
Atomic structures mapped in measles, mumps, flu and RSV: Discovery could give insight into coronavirus, which has similar features and functions Science Daily
Aridis Pharmaceuticals to Host Investor Day Showcasing APEX™ Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia BioSpace
Drugs for Respiratory Syncytial Virus (RSV) Industry Market 2019 Industry Outline, Global Executive Players, Interpretation and Benefit Growth to 2025 Keep Reading
Drugs for Respiratory Syncytial Virus (RSV) Market 2020 Analysis By Worldwide Industry Trends, Size, Share, Gross Margin, Future Demand, Analysis and Forecast by Top Leading Players till 2026 GuruFocus.com
Drugs for Respiratory Syncytial Virus (RSV) Market 2020 Analysis By Worldwide Industry Trends, Size, Share, Gross Margin, Future Demand, Analysis and Forecast by Top Leading Players till 2026 GuruFocus.com
Drugs for Respiratory Syncytial Virus (RSV) Market 2020 Analysis By Worldwide Industry Trends, Size, Share, Gross Margin, Future Demand, Analysis and Forecast by Top Leading Players till 2026 GuruFocus.com
Clover Successfully Produced 2019-nCoV Subunit Vaccine Candidate and Detected Cross-Reacting Antibodies from Sera of Multiple Infected Patients Business Wire
Clover Successfully Produced 2019-nCoV Subunit Vaccine Candidate and Detected Cross-Reacting Antibodies from Sera of Multiple Infected Patients BioSpace
Clover Successfully Produced 2019-nCoV Subunit Vaccine Candidate and Detected Cross-Reacting Antibodies from Sera of Multiple Infected Patients BioSpace
Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates Business Wire